ArticlePharmaceuticals (Basel, Switzerland)2025

Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach.

Tilal Elsaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.